UB CAT: Design of Parallel-Computing Platform to Develop a Multi-Scale, Physiological-Based, Drug-Disease Model for Therapeutic Monoclonal Antibodies Targeting Inflammatory Cytokine Mediators Involved in the Pathogenesis of Eosinophilic